about
A randomized, double-blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive-stage small cell lung cancer: Hoosier Cancer Research Network LUN06-113.Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study.
P50
description
researcher
@en
wetenschapper
@nl
name
Rachel E Sanborn
@en
Rachel E Sanborn
@nl
type
label
Rachel E Sanborn
@en
Rachel E Sanborn
@nl
prefLabel
Rachel E Sanborn
@en
Rachel E Sanborn
@nl
P31
P496
0000-0003-0542-6054